Patents by Inventor Elena Fisheleva

Elena Fisheleva has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • C-type natriuretic peptide variants to treat skeletal dysplasia in children
    Patent number: 12233106
    Abstract: treatment of skeletal dysplasias in children, and improvement in one or more symptoms of skeletal dysplasias, such as long bone growth or growth velocity, by administering variants of C-type natriuretic peptide (CNP) is described.
    Type: Grant
    Filed: July 11, 2022
    Date of Patent: February 25, 2025
    Assignee: BIOMARIN PHARMACEUTICAL INC.
    Inventors: Jonathan Day, Elena Fisheleva
  • CNP Therapy
    Publication number: 20250032576
    Abstract: The present disclosure relates, in general, to measures of efficacy in patients receiving C-type natriuretic peptide (CNP) therapy to treat a skeletal dysplasia, short stature or bone-related disorders.
    Type: Application
    Filed: December 7, 2022
    Publication date: January 30, 2025
    Inventors: George Jeha, Christopher Bauer, Sergio Covarrubias, Devanshi Shanghavi, Yu-Shan Tseng, Jonathan Day, Elena Fisheleva
  • C-Type Natriuretic Peptide Variants to Treat Skeletal Dysplasia in Children
    Publication number: 20230140311
    Abstract: The present disclosure provides for use of variants of C-type natriuretic peptide (CNP), for the treatment of skeletal dysplasias in children, and improvement in one or more symptoms of skeletal dysplasias, such as long bone growth or growth velocity, and use in other disorders having a skeletal dysplasia and/or CNP-associated symptom or component.
    Type: Application
    Filed: July 11, 2022
    Publication date: May 4, 2023
    Inventors: Jonathan Day, Elena Fisheleva